Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients

Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis

(2016) H. Kitt et al.   BMC Pharmacology & Toxicology

Impact of Sustained Eradication of NewPseudomonas aeruginosaInfection on Long-term Outcomes in Cystic Fibrosis

(2015) Nicole Mayer-Hamblett et al.   CLINICAL INFECTIOUS DISEASES

Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry

(2013) E. Kerem et al.   EUROPEAN RESPIRATORY JOURNAL

Factors Influencing Acquisition of Burkholderia cepacia Complex Organisms in Patients with Cystic Fibrosis

(2013) K. A. Ramsay et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis

(2012) M. Proesmans et al.   Journal of Cystic Fibrosis

Can Early Burkholderia cepacia Complex Infection in Cystic Fibrosis be Eradicated with Antibiotic Therapy?

(2011) Alex Horsley et al.   Frontiers in Cellular and Infection Microbiology

Cystic Fibrosis Pulmonary Guidelines

(2009) Patrick A. Flume et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Can Burkholderia cepacia complex be eradicated with nebulised Amiloride and TOBI®?

(2009) R. Ball et al.   Journal of Cystic Fibrosis